These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29169166)

  • 21. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 22. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
    Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
    Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
    Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
    JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Storebø OJ; Simonsen E; Gluud C
    JAMA; 2016 May; 315(18):2009-10. PubMed ID: 27163989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of methylphenidate in the treatment of encopresis whether or not attention-deficit/hyperactivity disorder symptoms are present.
    Yilmaz S; Akça OF
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):632-3. PubMed ID: 24251646
    [No Abstract]   [Full Text] [Related]  

  • 26. Attention deficit hyperactivity disorder: part III.
    Ryan-Krause P
    J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.
    Feldman HM; Reiff MI
    N Engl J Med; 2014 Feb; 370(9):838-46. PubMed ID: 24571756
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary on Greene and Ablon: What does the MTA study tell us about effective psychosocial treatment for ADHD?
    Harwood TM; Beutler LE
    J Clin Child Psychol; 2001 Mar; 30(1):141-3. PubMed ID: 11482297
    [No Abstract]   [Full Text] [Related]  

  • 29. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report.
    Schweickert LA; Strober M; Moskowitz A
    Int J Eat Disord; 1997 Apr; 21(3):299-301. PubMed ID: 9097204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of attention deficit disorder: new evidence.
    Harv Ment Health Lett; 2005 Jan; 21(7):6. PubMed ID: 15799110
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.
    Shaw P
    JAMA; 2016 May; 315(18):1953-5. PubMed ID: 27163984
    [No Abstract]   [Full Text] [Related]  

  • 35. Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?
    Mulder R; Hazell P; Rucklidge JJ; Malhi GS
    Aust N Z J Psychiatry; 2016 Feb; 50(2):113-4. PubMed ID: 26823533
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 37. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S; Tanidir C
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effectiveness of body-oriented methods of therapy in the treatment of attention-deficit hyperactivity disorder (ADHD): results of a controlled pilot study].
    Haffner J; Roos J; Goldstein N; Parzer P; Resch F
    Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):37-47. PubMed ID: 16485612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.